IDH1 mutations induce organelle defects via dysregulated phospholipids
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDH1 mutations induce organelle defects via dysregulated phospholipids
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-27
DOI
10.1038/s41467-020-20752-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
- (2020) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading
- (2020) David N. Louis et al. BRAIN PATHOLOGY
- mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated Glioma
- (2020) Yang Liu et al. Cancers
- MetaboAnalystR 3.0: Toward an Optimized Workflow for Global Metabolomics
- (2020) Zhiqiang Pang et al. Metabolites
- Spatial-fluxomics provides a subcellular-compartmentalized view of reductive glutamine metabolism in cancer cells
- (2019) Won Dong Lee et al. Nature Communications
- Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
- (2019) Daniel A. Pollyea et al. LEUKEMIA
- Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
- (2019) Zuzanna Tracz-Gaszewska et al. Cancers
- Toward Single-Organelle Lipidomics in Live Cells
- (2019) Adrian Lita et al. ANALYTICAL CHEMISTRY
- Should we consider subcellular compartmentalization of metabolites, and if so, how do we measure them?
- (2019) Kathryn E. Wellen et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma
- (2018) Steffen Dettling et al. CLINICAL CANCER RESEARCH
- MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
- (2018) Jasmine Chong et al. NUCLEIC ACIDS RESEARCH
- Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma
- (2018) Samuel K. McBrayer et al. CELL
- Targeting IDH1-Mutated Malignancies with NRF2 Blockade
- (2018) Yang Liu et al. JNCI-Journal of the National Cancer Institute
- Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
- (2017) Tatiana Altadill et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Lipids and Their Trafficking: An Integral Part of Cellular Organization
- (2016) Catherine L. Jackson et al. DEVELOPMENTAL CELL
- Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
- (2016) Changho Choi et al. JOURNAL OF CLINICAL ONCOLOGY
- GlioVis data portal for visualization and analysis of brain tumor expression datasets
- (2016) Robert L. Bowman et al. NEURO-ONCOLOGY
- Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment
- (2015) Patty W. Siri-Tarino et al. Annual Review of Nutrition
- The Reactome pathway Knowledgebase
- (2015) Antonio Fabregat et al. NUCLEIC ACIDS RESEARCH
- Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
- (2013) Ovidiu C. Andronesi et al. JOURNAL OF CLINICAL INVESTIGATION
- Mass spectrometry-based metabolomics of single yeast cells
- (2013) A. J. Ibanez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Golgi Membrane Dynamics and Lipid Metabolism
- (2012) Vytas A. Bankaitis et al. CURRENT BIOLOGY
- Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
- (2012) Roberta Leonardi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability
- (2011) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An allostatic control of membrane lipid composition by SREBP1
- (2010) Rachel M. Hagen et al. FEBS LETTERS
- Cancer-associated IDH mutations: biomarker and therapeutic opportunities
- (2010) K E Yen et al. ONCOGENE
- Journeys through the Golgi—taking stock in a new era
- (2009) Scott Emr et al. JOURNAL OF CELL BIOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation